Study reveals the how stress can induce sleep in mice, and how this stress-induced sleep can help reduce anxiety the following day.
Intermittent fasting alters the gut bacteria in mice, facilitating an increased ability for damaged nerves to recover.
A neuroimaging-based machine learning algorithm can detect Alzheimer's in the brain with 98% accuracy. The system is also 79% accurate at determining which stage of Alzheimer's disease a patient has.
People with depression who responded to psilocybin therapy showed an increase in brain connectivity for up to three weeks following treatment. The increased brain connectivity was correlated with self-reported improvements in depression symptoms.
Previous research indicated social isolation and loneliness is a driver of smoking behaviors. A new study reports smoking itself may lead to social isolation and loneliness.
Study reveals why human brains are so good at learning. The findings could help with the development of more efficient AI models.
Study reveals how the drosophila brain subconsciously processes salient information, such as odors, that require interpretation while asleep.
A new study adds to the growing body of research linking inflammation to depression. Researchers found the molecule histamine directly inhibits the release of serotonin in the brain by attaching to inhibitory receptors on serotonin neurons in mice.
Neuroimaging study reveals three distinct response types in brain areas that control hunger, food intake, and appetite in patients who had undergone weight loss surgery.
From treating depression and other mental health disorders, to helping relieve chronic pain, researchers discuss the advantages and implications of psychedelic treatments.
Neuroimaging study revealed a significant number of professional rugby players had white matter abnormalities and abnormal changes to white matter volume over time.
Psilocybin, the psychoactive compound found in magic mushrooms, is as effective at treating depression as conventional SSRI antidepressants. Researchers report, that although not significantly significant, early findings reveal those treated with psilocybin experienced more rapid and greater reductions in depression symptoms than those treated with SSRIs.
